JP2016519664A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016519664A5 JP2016519664A5 JP2016502561A JP2016502561A JP2016519664A5 JP 2016519664 A5 JP2016519664 A5 JP 2016519664A5 JP 2016502561 A JP2016502561 A JP 2016502561A JP 2016502561 A JP2016502561 A JP 2016502561A JP 2016519664 A5 JP2016519664 A5 JP 2016519664A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- bacterial
- bacteria
- clade
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798666P | 2013-03-15 | 2013-03-15 | |
| US61/798,666 | 2013-03-15 | ||
| PCT/US2014/030817 WO2014145958A2 (en) | 2013-03-15 | 2014-03-17 | Network-based microbial compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019088423A Division JP7136743B2 (ja) | 2013-03-15 | 2019-05-08 | ネットワークを基にした微生物組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016519664A JP2016519664A (ja) | 2016-07-07 |
| JP2016519664A5 true JP2016519664A5 (https=) | 2017-02-02 |
| JP2016519664A6 JP2016519664A6 (https=) | 2019-10-17 |
Family
ID=51538577
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502561A Pending JP2016519664A (ja) | 2013-03-15 | 2014-03-17 | ネットワークを基にした微生物組成物及び方法 |
| JP2019088423A Active JP7136743B2 (ja) | 2013-03-15 | 2019-05-08 | ネットワークを基にした微生物組成物及び方法 |
| JP2022138978A Pending JP2022188020A (ja) | 2013-03-15 | 2022-09-01 | ネットワークを基にした微生物組成物及び方法 |
| JP2024141842A Pending JP2024167277A (ja) | 2013-03-15 | 2024-08-23 | ネットワークを基にした微生物組成物及び方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019088423A Active JP7136743B2 (ja) | 2013-03-15 | 2019-05-08 | ネットワークを基にした微生物組成物及び方法 |
| JP2022138978A Pending JP2022188020A (ja) | 2013-03-15 | 2022-09-01 | ネットワークを基にした微生物組成物及び方法 |
| JP2024141842A Pending JP2024167277A (ja) | 2013-03-15 | 2024-08-23 | ネットワークを基にした微生物組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10076546B2 (https=) |
| EP (1) | EP2967077A4 (https=) |
| JP (4) | JP2016519664A (https=) |
| AU (3) | AU2014232370B2 (https=) |
| HK (1) | HK1220326A1 (https=) |
| WO (1) | WO2014145958A2 (https=) |
Families Citing this family (139)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3564357T3 (da) | 2010-02-01 | 2022-06-20 | Rebiotix Inc | Bakterieterapi mod clostridium difficile colitis |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| ES2993669T3 (en) | 2011-12-01 | 2025-01-03 | Univ Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| CA3008794C (en) | 2012-03-29 | 2021-03-16 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
| SG11201503966PA (en) | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| AU2014239883B2 (en) | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
| JP6637885B2 (ja) | 2013-07-21 | 2020-01-29 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム |
| CN105979952B (zh) | 2013-11-25 | 2022-04-08 | 赛里斯治疗公司 | 协同细菌组合物以及其制造方法和用途 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| EP3134509B1 (en) * | 2014-04-23 | 2026-01-21 | Cornell University | Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract |
| US10346592B2 (en) | 2014-10-21 | 2019-07-09 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
| US10395777B2 (en) | 2014-10-21 | 2019-08-27 | uBiome, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
| US10357157B2 (en) | 2014-10-21 | 2019-07-23 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features |
| WO2016065075A1 (en) | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| CA2964480A1 (en) * | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| AR103260A1 (es) | 2014-12-23 | 2017-04-26 | 4D Pharma Res Ltd | Modulación inmunitaria |
| EP3400953A1 (en) | 2014-12-23 | 2018-11-14 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
| US20180030516A1 (en) * | 2015-02-27 | 2018-02-01 | Alere Inc. | Microbiome Diagnostics |
| WO2016183535A1 (en) | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
| PE20180673A1 (es) * | 2015-06-01 | 2018-04-19 | Univ Chicago | Tratamiento contra el cancer por manipulacion de la microflora comensal |
| US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| ES2889902T3 (es) | 2015-06-09 | 2022-01-14 | Rebiotix Inc | Métodos de fabricación de composiciones para terapia de restauración de la microbiota (TRM) |
| US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
| WO2016203221A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| SMT201900588T1 (it) | 2015-06-15 | 2019-11-13 | 4D Pharma Res Limited | Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| NZ737752A (en) | 2015-06-15 | 2022-02-25 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| AU2016318112B2 (en) * | 2015-09-04 | 2021-11-04 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for detecting risk of cancer relapse |
| CN108513545B (zh) | 2015-11-20 | 2020-11-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| WO2017117142A1 (en) | 2015-12-28 | 2017-07-06 | New York University | Device and method of restoring microbiota of newborns |
| CA3008156C (en) | 2015-12-31 | 2022-05-10 | Caelus Pharmaceuticals B.V. | Method for culturing and preserving eubacterium hallii |
| CN105524907B (zh) * | 2016-02-01 | 2018-12-04 | 江南大学 | 一种底物专一性提高的胆盐水解酶突变体 |
| EP3639834B1 (en) | 2016-02-04 | 2023-07-12 | Universiteit Gent | Use of microbial communities for human and animal health |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| CN115887508A (zh) | 2016-03-04 | 2023-04-04 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
| ME03487B (me) | 2016-03-04 | 2020-01-20 | 4D Pharma Plc | Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti |
| CN108699586B (zh) * | 2016-03-07 | 2022-09-20 | 普梭梅根公司 | 用于表征与口相关病症的方法和系统 |
| EP3429604A1 (en) | 2016-03-14 | 2019-01-23 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
| CA3019732A1 (en) * | 2016-04-05 | 2017-10-12 | Nch Corporation | Nutrient rich germinant composition and spore incubation method |
| AU2017249159B2 (en) * | 2016-04-11 | 2024-06-13 | President And Fellows Of Harvard College | Probiotic formulations for improving athletic performance |
| EP4302824A3 (en) | 2016-04-20 | 2024-03-20 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
| CA3226196A1 (en) | 2016-06-14 | 2017-12-21 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| US9999641B2 (en) | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| KR101815692B1 (ko) | 2016-07-25 | 2018-01-16 | 주식회사 고바이오랩 | 구강 세균의 군집을 이용한 대사성 질환 진단용 바이오 마커 |
| US10441612B2 (en) * | 2016-08-16 | 2019-10-15 | Taichung Veterans General Hospital | Intestinal microbe therapy, composition therefor and method for preparing the same |
| JP6408092B2 (ja) * | 2016-08-29 | 2018-10-17 | 国立大学法人 東京大学 | 糞便微生物叢を含む組成物 |
| CN109219656B (zh) * | 2016-09-06 | 2025-12-09 | 深圳华大生命科学研究院 | 长栖粪杆菌（Faecalibacterium longum）及其应用 |
| US10428370B2 (en) * | 2016-09-15 | 2019-10-01 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| FI20165932A7 (fi) * | 2016-12-07 | 2018-06-08 | Uute Scient Oy | Immunomodulatorisia koostumuksia |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| US11566238B2 (en) | 2016-12-15 | 2023-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| US10783437B2 (en) * | 2017-03-05 | 2020-09-22 | International Business Machines Corporation | Hybrid aggregation for deep learning neural networks |
| US10733214B2 (en) | 2017-03-20 | 2020-08-04 | International Business Machines Corporation | Analyzing metagenomics data |
| EP3606325B1 (en) * | 2017-04-03 | 2024-09-04 | Gusto Global, LLC | Rational design of microbial-based biotherapeutics |
| EP3388069B1 (en) | 2017-04-12 | 2019-05-01 | ETH Zurich | Consortia of living bacteria useful for treatment of microbiome dysbiosis |
| WO2018197951A1 (en) * | 2017-04-28 | 2018-11-01 | Allen Vercoe Emma | Methods and compositions for storing bacteria |
| DK3630136T3 (da) | 2017-05-22 | 2021-05-25 | 4D Pharma Res Ltd | Sammensætninger, der omfatter bakteriestammer |
| EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
| SMT202000695T1 (it) | 2017-06-14 | 2021-01-05 | 4D Pharma Res Limited | Composizioni comprendenti ceppi batterici |
| SMT202000555T1 (it) | 2017-06-14 | 2020-11-10 | 4D Pharma Res Limited | Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi |
| CA3066189A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| WO2019014714A1 (en) | 2017-07-17 | 2019-01-24 | smartDNA Pty Ltd | DIAGNOSTIC METHOD OF DYSBIOSIS |
| AU2018309153A1 (en) * | 2017-08-04 | 2020-03-19 | Tarunmeet GUJRAL | Roseburia hominis, Eubacterium eligens, and combinations thereof as biotherapeutics |
| EP3662087B1 (en) * | 2017-08-06 | 2022-10-05 | Second Genome, Inc. | Streptococcus australis as a biotherapeutics |
| AU2018313765A1 (en) * | 2017-08-07 | 2020-02-27 | Finch Therapeutics, Inc. | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut |
| EP3668527A1 (en) | 2017-08-14 | 2020-06-24 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| BR112020008552A2 (pt) * | 2017-10-30 | 2020-12-29 | Seres Therapeutics, Inc. | métodos e composições para tratamento de resistência a antibiótico |
| AU2018379996A1 (en) | 2017-12-05 | 2020-06-25 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| WO2019118984A2 (en) * | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| JP7325106B2 (ja) * | 2018-02-09 | 2023-08-14 | Ｎｏｓｔｅｒ株式会社 | リポ多糖制御性腸内細菌及びその用途 |
| WO2019178494A1 (en) * | 2018-03-15 | 2019-09-19 | Evelo Biosciences, Inc. | Compositions and methods for treating cancer and inflammation using tyzzerella nexilis |
| EP3773645A4 (en) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | MICROBIAL CONSORTIA |
| AU2019253616A1 (en) * | 2018-04-13 | 2020-11-05 | Med-Life Discoveries Lp | Long chain dicarboxylic fatty acid (LCDFA) producing microbes and uses thereof |
| EP3823651A4 (en) | 2018-07-19 | 2022-04-27 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION |
| CN108977395B (zh) * | 2018-07-31 | 2022-03-22 | 李昕 | 钝化固化修复土壤六价铬污染的生物纳米材料的制备方法 |
| AU2019321681A1 (en) | 2018-08-17 | 2021-02-25 | Vedanta Biosciences, Inc. | Methods of decreasing dysbiosis and restoring a microbiome |
| CA3111795A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US12144834B2 (en) | 2018-09-13 | 2024-11-19 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| ES3023269T3 (en) | 2018-09-13 | 2025-05-30 | Gnubiotics Sciences Sa | Microbiome markers and uses thereof |
| WO2020068936A1 (en) * | 2018-09-25 | 2020-04-02 | Duke University | Methods and compositions to treat and prevent infection |
| WO2020093040A1 (en) * | 2018-11-02 | 2020-05-07 | The Regents Of The University Of California | Methods to diagnose and treat cancer using non-human nucleic acids |
| SG11202105284YA (en) * | 2018-11-21 | 2021-06-29 | Chan Zuckerberg Biohub Inc | High-complexity synthetic gut bacterial communities |
| KR20210100662A (ko) * | 2018-12-05 | 2021-08-17 | 세레스 테라퓨틱스, 인코포레이티드 | 박테리아를 안정화시키는 조성물 그리고 이의 용도 |
| WO2020154397A1 (en) * | 2019-01-22 | 2020-07-30 | The Regents Of The University Of California | Bile acids and use in disease treatment |
| US11270791B2 (en) * | 2019-03-30 | 2022-03-08 | Tata Chemicals Limited | In silico methods for obtaining nutraceutical compositions |
| SG11202111168UA (en) | 2019-04-09 | 2021-11-29 | Dermbiont Inc | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes |
| PH12021553137A1 (en) * | 2019-07-19 | 2022-07-25 | Finch Therapeutics Holdings Llc | Methods and products for treatment of gastrointestinal disorders |
| WO2021033042A1 (en) * | 2019-08-16 | 2021-02-25 | Janssen Biotech, Inc. | Optimized culture media for clostridia bacteria |
| JP2022548785A (ja) | 2019-09-24 | 2022-11-21 | プロラクタ バイオサイエンス，インコーポレイテッド | 炎症性疾患及び免疫疾患の治療のための組成物及び方法 |
| CN120732903A (zh) | 2019-10-07 | 2025-10-03 | 谢尔塔治疗公司 | 治疗性药物组合物 |
| EP4042165B1 (en) * | 2019-10-11 | 2023-11-15 | Société des Produits Nestlé S.A. | 2-methylbutyrate, a biomarker for improvements of mood disorders |
| EP3808358A1 (en) * | 2019-10-17 | 2021-04-21 | University College Cork-National University of Ireland, Cork | Microbial compositions, strains and methods |
| IL271775A (en) * | 2019-12-31 | 2021-06-30 | Biomica Ltd | Microbial consortium and uses thereof |
| US20230035667A1 (en) * | 2020-01-17 | 2023-02-02 | Second Genome, Inc. | Methods and compositions for treating type 2 diabetes |
| WO2021163212A1 (en) | 2020-02-10 | 2021-08-19 | Native Microbials, Inc. | Microbial compositions and methods of use for canine enteropathy and dysbiosis |
| EP3875098A1 (en) * | 2020-03-04 | 2021-09-08 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Use of coprococcus bacteria for the treatment of metabolic syndrome and inflammatory bowel diseases |
| CA3175041A1 (en) * | 2020-03-10 | 2021-09-16 | Federation Bio Inc. | Microbial consortia for the treatment of disease |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| GB202007452D0 (en) * | 2020-05-19 | 2020-07-01 | Microbiotica Ltd | Threrapeutic bacterial composition |
| EP4152959A4 (en) * | 2020-05-21 | 2024-07-03 | Chan Zuckerberg Biohub, Inc. | HIGH COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| WO2022027040A2 (en) | 2020-07-28 | 2022-02-03 | Icahn School Of Medicine At Mount Sinai | Compositions and methods for treating infections of the gastrointestinal tract |
| KR20230088680A (ko) | 2020-08-14 | 2023-06-20 | 프롤랙타 바이오사이언스, 인코포레이티드 | 박테리아 요법에 사용하기 위한 인간 모유 올리고당 조성물 |
| JP7510824B2 (ja) * | 2020-09-02 | 2024-07-04 | 日清食品ホールディングス株式会社 | Ｉｌ－１７の産生を抑制するビフィズス菌 |
| US20240269198A1 (en) * | 2020-10-14 | 2024-08-15 | Dermbiont, Inc. | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with fungi and other pathogenic microbes |
| WO2022115646A1 (en) * | 2020-11-25 | 2022-06-02 | Seres Therapeutics, Inc. | Designed bacterial compositions for treating graft-versus-host-disease |
| KR102296290B1 (ko) * | 2020-12-31 | 2021-09-01 | 주식회사 바이오뱅크힐링 | 비피도박테리움 아돌레센티스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
| IL305830A (en) * | 2021-03-12 | 2023-11-01 | Marvelbiome Inc | Methods and uses of microbiome compositions, components or metabolites for the treatment of eye disorders |
| US12011467B2 (en) | 2021-05-18 | 2024-06-18 | J. Craig Venter Institute, Inc. | Bacterial formulation |
| CN113337436A (zh) * | 2021-06-09 | 2021-09-03 | 中国科学院新疆生态与地理研究所 | 一种尿素分解菌及其选育方法和应用 |
| CN113493847B (zh) * | 2021-06-24 | 2022-04-19 | 北京工业大学 | 基于PMA高通量测序和PICRUSt的抗生素抗性基因及潜在宿主细菌的鉴定方法 |
| CA3238788A1 (en) | 2021-11-22 | 2023-05-25 | Eric Michael Schott | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| EP4478893A4 (en) * | 2022-02-15 | 2025-05-21 | The Regents of the University of California | Methods, devices, and systems for determining the functional microbial niche and identifying interventions in complex heterogeneous communities |
| US20240033217A1 (en) | 2022-08-01 | 2024-02-01 | Novel Biome Solutions Inc. | Method of orally administering a fecal microbiota transplant composition |
| JP7279983B1 (ja) | 2022-09-21 | 2023-05-23 | 学校法人近畿大学 | 腸内細菌培養組培地、及び腸内細菌培養方法。 |
| JP2024076476A (ja) * | 2022-11-25 | 2024-06-06 | ノバセル株式会社 | Ｔｖｃｍの案を評価するための装置、方法及びそのためのプログラム |
| WO2025030167A2 (en) * | 2023-08-03 | 2025-02-06 | University Of Virginia Patent Foundation | Compositions, systems, and methods relating to predictive microbiome transplantation and clostridioides difficile therapies |
| WO2025048282A1 (ko) * | 2023-08-30 | 2025-03-06 | 아주대학교산학협력단 | 박테로이데스 에게르티 kgmb05336 균주 및 이의 용도 |
Family Cites Families (162)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3009864A (en) | 1958-09-18 | 1961-11-21 | Union Carbide Corp | Process control |
| US3228838A (en) | 1959-04-23 | 1966-01-11 | Union Carbide Corp | Preservation of biological substances |
| US3009861A (en) | 1961-01-13 | 1961-11-21 | Alderton Gordon | Isolation of bacterial spores |
| US3608030A (en) | 1969-05-21 | 1971-09-21 | Howard Tint | Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
| US4077227A (en) | 1976-11-12 | 1978-03-07 | Regents Of The University Of Minnesota | Method of freezing liquid material in which agglomeration is inhibited |
| US4205132A (en) | 1978-07-17 | 1980-05-27 | Microlife Technics, Inc. | Lyophilization of bacteria |
| FI59925C (fi) | 1980-01-11 | 1981-11-10 | Esko Viljo Nurmi | Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae |
| US4655047A (en) | 1985-03-25 | 1987-04-07 | I.Q.F. Inc. | Process for freezing or chilling |
| JPS61252212A (ja) | 1985-04-12 | 1986-11-10 | Mitsubishi Petrochem Co Ltd | 高吸水性ポリマ−の製造方法 |
| US4839281A (en) | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
| DE3887353T2 (de) | 1987-10-12 | 1994-05-05 | Capability Services Pty Ltd | Behandlungsverfahren für magen-darm-krankheiten. |
| US5045446A (en) | 1988-08-26 | 1991-09-03 | Cryopharm Corporation | Lyophilization of cells |
| US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
| DE68928665T2 (de) | 1988-08-02 | 1998-11-12 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
| GB2233343B (en) | 1989-06-30 | 1993-07-07 | Farmos Oy | A bacterial preparation for use in poultry |
| JP2961182B2 (ja) | 1990-03-09 | 1999-10-12 | ミヤリサン株式会社 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
| JP2961184B2 (ja) | 1990-05-07 | 1999-10-12 | ミヤリサン株式会社 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
| US5436002A (en) | 1991-01-29 | 1995-07-25 | Mycogen Corporation | Bacillus thuringiensisisolate PS201T6 toxin |
| RU2035186C1 (ru) | 1992-07-09 | 1995-05-20 | Семен Рафаилович Резник | Профилактический биопрепарат споролакт |
| ES2157225T3 (es) | 1992-10-09 | 2001-08-16 | Advanced Tissue Sciences Inc | Celulas hepaticas de reserva. |
| US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
| ES2248822T3 (es) | 1995-09-15 | 2006-03-16 | Dale N. Gerding | Procedimientos y composiciones para la prevencion y el tratamiento de enfermedades asociadas al clostridium difficile. |
| AUPO430496A0 (en) | 1996-12-19 | 1997-01-23 | Arnott's Biscuits Limited | Prebiotics and probiotics |
| US5965128A (en) | 1997-08-13 | 1999-10-12 | University Of Georgia Research Foundation Inc. | Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli |
| US5951977A (en) | 1997-10-14 | 1999-09-14 | The United States Of America, As Represented By The Secretary Of Agriculture | Competitive exclusion culture for swine |
| US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
| US6589771B1 (en) | 1999-10-28 | 2003-07-08 | Immunom Technologies, Inc. | Methods for arousing dormant bacteria |
| US20030118547A1 (en) | 2000-01-27 | 2003-06-26 | Vandenberg Grant William | Composition for intestinal delivery |
| AU2001233529A1 (en) | 2000-02-10 | 2001-08-20 | Andrew W. Bruce | Probiotic therapy for newborns |
| US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
| US20020013270A1 (en) | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| AU2100402A (en) | 2000-11-30 | 2002-06-11 | Bio Balance Corp | Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| CN1678735A (zh) | 2001-05-04 | 2005-10-05 | 佛罗里达大学研究基金会有限公司 | 来源于细菌的丙酮酸脱羧酶(pdc)基因的克隆和测序及其用途 |
| ITMI20011632A1 (it) | 2001-07-27 | 2003-01-27 | Sanofi Synthelabo | Composizione solida contenente spore di batteri non patogeni del genere bacillus |
| GB0130789D0 (en) | 2001-12-21 | 2002-02-06 | King S College London | Application of spores |
| US8383342B2 (en) | 2002-04-24 | 2013-02-26 | The University Of North Carolina At Greensboro | Compositions, products, methods and systems to monitor water and other ecosystems |
| GB0212975D0 (en) | 2002-06-06 | 2002-07-17 | Mars Uk Ltd | Mammalian animal composition |
| AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| AU2003303894A1 (en) | 2003-01-30 | 2004-08-30 | The Regents Of The University Of California | Inactivated probiotic bacteria and methods of use thereof |
| WO2004101770A1 (en) | 2003-03-13 | 2004-11-25 | Universite De Moncton (Bureau De Soutien A L'innovation) | Antioxidant producing bacterium and uses thereof |
| AU2004232362C1 (en) | 2003-04-23 | 2008-05-29 | E. R. Squibb & Sons, L.L.C. | Compositions and methods for the therapy of inflammatory bowel disease |
| US20060046246A1 (en) | 2003-04-24 | 2006-03-02 | Qiandong Zeng | Genus, group, species and/or strain specific 16S rDNA sequences |
| WO2004104175A2 (en) | 2003-05-14 | 2004-12-02 | University Of Georgia Research Foundation, Inc. | Probiotic bacteria and methods |
| KR20060073937A (ko) | 2003-08-18 | 2006-06-29 | 더 바이오 밸런스 코포레이션 | 안정한 액상 촉생제 조성물, 그의 제조 및 응용 |
| US20050048515A1 (en) | 2003-08-29 | 2005-03-03 | Garner Bryan E. | Methods for detecting and quantifying specific probiotic microorganisms in animal feed |
| US7731976B2 (en) | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
| US20050239706A1 (en) | 2003-10-31 | 2005-10-27 | Washington University In St. Louis | Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| HUE024565T2 (hu) | 2004-02-03 | 2016-02-29 | Prevtec Microbia Inc | Élõ baktériumok alkalmazása növekedésserkentésre állatokban |
| US7632520B2 (en) | 2004-02-16 | 2009-12-15 | Sanjeev Khandelwal | Synergistic antibacterial formulation and to a method of making the same |
| US7854927B2 (en) | 2004-05-11 | 2010-12-21 | Ganeden Biotech, Inc. | Methods and compositions for the dietary management of autoimmune disorders |
| US20090197249A1 (en) | 2004-11-01 | 2009-08-06 | George Mason University | Compositions and methods for diagnosing colon disorders |
| PL1812585T3 (pl) | 2004-11-01 | 2015-03-31 | Erber Ag | Bakteriofagi jako czynniki selekcyjne |
| US20060188523A1 (en) | 2005-01-10 | 2006-08-24 | Zhiheng Pei | Methods for diagnosing and treating chronic tonsillitis |
| US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
| AU2006253007B2 (en) | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
| US7452872B2 (en) | 2005-08-24 | 2008-11-18 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
| EP1931363B1 (en) | 2005-09-28 | 2015-11-18 | Nordisk Rebalance A/S | Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| JP2009537138A (ja) | 2006-05-18 | 2009-10-29 | バイオバランス エルエルシー | 細菌株、この細菌株を含む組成物およびそのプロバイオティック使用 |
| JP5019563B2 (ja) | 2006-06-16 | 2012-09-05 | 旭化成ケミカルズ株式会社 | 腸内細菌賦活剤 |
| RU2009101475A (ru) | 2006-06-20 | 2010-07-27 | Конинклейке Филипс Электроникс, Н.В. (Nl) | Электронная капсула и способ для лечения желудочно-кишечного заболевания |
| TW200819540A (en) | 2006-07-11 | 2008-05-01 | Genelux Corp | Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders |
| EE05459B1 (et) | 2006-12-08 | 2011-08-15 | Tartu �likool | Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon |
| EP2102350A4 (en) | 2006-12-18 | 2012-08-08 | Univ St Louis | DARMMICROBIOMA AS A BIOMARKER AND THERAPEUTIC OBJECT FOR THE TREATMENT OF ADIPOSITAS OR ADIPOSITASCONDUCTIVE DISEASES |
| DE102006062250A1 (de) | 2006-12-22 | 2008-06-26 | Roland Saur-Brosch | Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden |
| WO2008083157A2 (en) | 2006-12-29 | 2008-07-10 | Washington University In St. Louis | Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject |
| WO2009036121A1 (en) | 2007-09-12 | 2009-03-19 | Targanta Therapeutics Corp. | Method of inhibiting clostridium difficile by administration of oritavancin |
| US8469648B2 (en) * | 2007-10-24 | 2013-06-25 | T&T Engineering Services | Apparatus and method for pre-loading of a main rotating structural member |
| JP2011503232A (ja) | 2007-11-20 | 2011-01-27 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | 免疫応答の調節 |
| US8236508B2 (en) | 2008-01-29 | 2012-08-07 | Drexel University | Detecting and measuring live pathogens utilizing a mass detection device |
| US8021654B2 (en) | 2008-03-14 | 2011-09-20 | Danisco A/S | Methods of treating pigs with Bacillus strains |
| RU2010144789A (ru) | 2008-04-01 | 2012-05-10 | Метаметрикс Клиникал Лэборетери (Us) | Процесс и способ мониторинга желудочно-кишечной микрофлоры |
| CN102940652B (zh) | 2008-05-28 | 2015-03-25 | 青岛东海药业有限公司 | 两形真杆菌制剂及其应用 |
| WO2010007106A1 (en) | 2008-07-15 | 2010-01-21 | Metanomics Health Gmbh | Means and methods diagnosing gastric bypass and conditions related thereto |
| CN102131928A (zh) | 2008-08-26 | 2011-07-20 | 奥林巴斯株式会社 | 粪便试样的调制方法、粪便试样调制用溶液、及粪便采集用试剂盒 |
| WO2010030997A1 (en) | 2008-09-12 | 2010-03-18 | The Washington University | Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss |
| US9603876B2 (en) | 2008-09-25 | 2017-03-28 | New York University | Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment |
| JP5620392B2 (ja) | 2008-11-03 | 2014-11-05 | タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ | クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物 |
| GB0821913D0 (en) | 2008-12-02 | 2009-01-07 | Price & Co | Antibacterial compounds |
| IT1393931B1 (it) | 2009-02-25 | 2012-05-17 | Neuroscienze Pharmaness S C A R L | Composizione di spore di batteri non patogeni |
| US20120128633A1 (en) | 2009-04-30 | 2012-05-24 | Campagnie Gervaise Donone | Use of collinsella aerofaciens for reducing bloating |
| HRP20160598T4 (hr) | 2009-05-01 | 2019-06-28 | Uas Laboratories Llc | Bakterijski sastavi za prevenciju i liječenje degenerativne bolesti |
| US9050276B2 (en) | 2009-06-16 | 2015-06-09 | The Trustees Of Columbia University In The City Of New York | Autism-associated biomarkers and uses thereof |
| US20120165215A1 (en) | 2009-06-26 | 2012-06-28 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
| WO2011046614A2 (en) | 2009-10-16 | 2011-04-21 | The Regents Of The University Of California | Methods and systems for phylogenetic analysis |
| WO2011005756A1 (en) | 2009-07-06 | 2011-01-13 | Puretech Ventures, Llc | Delivery of agents targeted to microbiota niches |
| CN102695427B (zh) | 2009-08-18 | 2016-04-13 | 雀巢产品技术援助有限公司 | 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物 |
| WO2011022542A2 (en) | 2009-08-19 | 2011-02-24 | Puretech Ventures, Llc | Administration of factors normally present in a microbial niche to improve health |
| US20120149584A1 (en) | 2009-08-21 | 2012-06-14 | Bernat Olle | Methods of diagnosing and treating microbiome-associated disease using interaction network parameters |
| GB0916335D0 (en) | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
| PL2480255T3 (pl) | 2009-09-23 | 2018-07-31 | Thomas Julius Borody | Terapia przewlekłych zakażeń jelitowych |
| CA2776420A1 (en) | 2009-10-05 | 2011-04-14 | Aak Patent B.V. | Methods for diagnosing irritable bowel syndrome |
| US20110081320A1 (en) | 2009-10-06 | 2011-04-07 | Nubiome, Inc. | Treatment/Cure of Autoimmune Disease |
| WO2011046616A2 (en) | 2009-10-15 | 2011-04-21 | New York University | Methods for modulating bacterial infection |
| WO2011060123A1 (en) | 2009-11-12 | 2011-05-19 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
| AU2010339573B2 (en) | 2009-12-31 | 2014-08-28 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
| US9492487B2 (en) | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
| DK3564357T3 (da) | 2010-02-01 | 2022-06-20 | Rebiotix Inc | Bakterieterapi mod clostridium difficile colitis |
| WO2011103123A2 (en) | 2010-02-16 | 2011-08-25 | Arizona Technology Enterprises | Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities |
| US20130005586A1 (en) | 2010-03-01 | 2013-01-03 | Stanislav Ehrlich | Method of diagnostic of obesity |
| US20130045874A1 (en) | 2010-03-01 | 2013-02-21 | Institut National De La Recherche Agronomique | Method of Diagnostic of Inflammatory Bowel Diseases |
| IT1398553B1 (it) | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
| WO2011113801A1 (en) | 2010-03-16 | 2011-09-22 | Universiteit Gent | Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
| US8951512B2 (en) | 2010-05-04 | 2015-02-10 | New York University | Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| EP2591114B1 (en) | 2010-07-06 | 2016-06-08 | GlaxoSmithKline Biologicals SA | Immunisation of large mammals with low doses of rna |
| WO2012009712A2 (en) | 2010-07-16 | 2012-01-19 | The Board Of Trustees Of The University Of Arkansas | Methods and compositions including spore-forming bacteria for increasing the health of animals |
| FI20105825A7 (fi) | 2010-07-26 | 2012-01-27 | Suomen Punainen Risti Veripalvelu | Veriryhmästatuksen käyttö III |
| EP3424515A3 (en) | 2010-08-04 | 2019-06-19 | Thomas Julius Borody | Stool collection devices and methods for using them |
| US9386793B2 (en) | 2010-08-20 | 2016-07-12 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
| EP2613802A4 (en) | 2010-09-10 | 2014-03-26 | Viropharma Inc | ENVIRONMENTAL CLOSTRIDAL BACTERIOTHERAPY AND ASSOCIATED FORMULATIONS AND METHODS OF MAKING AND USING SAME |
| EP2646567A4 (en) | 2010-10-04 | 2014-03-26 | British Columbia Cancer Agency | DETECTION OF FUSOBACTERIUM IN A GASTROINTESTINAL SAMPLE FOR THE DIAGNOSIS OF GASTROINTESTINAL CARCINOMA |
| US8802099B2 (en) | 2010-11-10 | 2014-08-12 | National Jewish Health | Methods to treat allergic conditions |
| US20120064592A1 (en) | 2011-01-26 | 2012-03-15 | Qteros, Inc. | Biocatalysts synthesizing deregulated cellulases |
| CN103491969A (zh) | 2011-02-09 | 2014-01-01 | 拉维沃公司 | 恢复和重建肠道微生物群的合生素组合物 |
| AR085409A1 (es) | 2011-02-25 | 2013-10-02 | Tricorder Diagnostics Llc | Firmas microbianas como indicadores de exposicon a radiacion |
| US9968638B2 (en) | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| WO2012122522A2 (en) | 2011-03-09 | 2012-09-13 | Washington University | Cultured collection of gut microbial community |
| WO2012142605A1 (en) * | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
| US20120276056A1 (en) | 2011-04-26 | 2012-11-01 | Wieslaw Janusz Bochenek | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine |
| WO2012159023A2 (en) | 2011-05-19 | 2012-11-22 | Virginia Commonwealth University | Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction |
| US9579353B2 (en) | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
| WO2013008102A2 (en) | 2011-07-14 | 2013-01-17 | R.E.D. Laboratories N.V../ S.A. | Methods and compositions for evaluating and/or treating chronic immune diseases |
| US20130022575A1 (en) | 2011-07-19 | 2013-01-24 | Microbial Rx | Systems and methods of replacing intestinal flora |
| WO2013016636A1 (en) | 2011-07-27 | 2013-01-31 | Max International, Llc | Compositions comprising sugar-cysteine products |
| WO2013019896A1 (en) | 2011-08-01 | 2013-02-07 | Symbiotix Biotherapies, Inc. | Platform for identifying and/or characterizing immunomodulatory agents |
| KR101982491B1 (ko) | 2011-08-30 | 2019-05-27 | 아카데미쉬 메디쉬 센트륨 | 인슐린 저항 예방 및/또는 치료 방법 |
| US20140363397A1 (en) | 2011-09-14 | 2014-12-11 | Queen's University At Kingston | Method for treatment of disorders of the gastrointestinal system |
| US20130115232A1 (en) | 2011-10-03 | 2013-05-09 | Fred Hutchinson Cancer Research Center | Methods for detecting graft-versus-host disease |
| US20130121968A1 (en) | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
| GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| CN103857402A (zh) | 2011-10-11 | 2014-06-11 | 阿基姆医药公司 | 包括厌氧培养的人类肠道微生物群的组合物 |
| ES2993669T3 (en) | 2011-12-01 | 2025-01-03 | Univ Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| GB201201766D0 (en) | 2012-02-01 | 2012-03-14 | Imp Innovations Ltd | Method |
| US20150125883A1 (en) | 2012-04-30 | 2015-05-07 | Washington University | Method of isolating and characterizing microorganisms that are targets of host immune responses |
| US10130665B2 (en) | 2012-05-18 | 2018-11-20 | Genome Research Limited | Method for identifying bacteria for bacteriotherapy |
| AU2013266069B2 (en) | 2012-05-25 | 2018-03-15 | Sloan Kettering Institute For Cancer Research | Methods for treating GI syndrome and graft versus host disease |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| EP2684469A1 (en) | 2012-07-13 | 2014-01-15 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| SG11201503966PA (en) | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| JP2016509003A (ja) | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | 組成物および方法 |
| EP2971148A4 (en) | 2013-03-14 | 2016-08-17 | Seres Therapeutics Inc | METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS |
| WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
| EP2991659B1 (en) | 2013-05-03 | 2018-10-10 | Nestec S.A. | Lachnospiraceae in the gut microbiota and association with body weight |
| WO2015018307A1 (en) | 2013-08-06 | 2015-02-12 | Bgi Shenzhen Co., Limited | Biomarkers for colorectal cancer |
| CN105979952B (zh) | 2013-11-25 | 2022-04-08 | 赛里斯治疗公司 | 协同细菌组合物以及其制造方法和用途 |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| EP3319619A4 (en) | 2015-07-08 | 2019-01-02 | Seres Therapeutics, Inc. | Methods of treating colitis |
| US10300043B2 (en) | 2015-08-12 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof |
| WO2017074257A1 (en) | 2015-10-26 | 2017-05-04 | Nanyang Technological University | Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents |
| PL3380108T3 (pl) | 2015-11-24 | 2023-03-27 | Seres Therapeutics, Inc. | Zaprojektowane kompozycje bakteryjne |
| WO2017091753A1 (en) | 2015-11-25 | 2017-06-01 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization |
| KR20180094950A (ko) | 2015-12-14 | 2018-08-24 | 메타보겐 에이비 | 간내 담즙정체증 및 관련 간 질환들의 치료 |
| EP3429604A1 (en) | 2016-03-14 | 2019-01-23 | Holobiome, Inc. | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system |
| BR112020006731A2 (pt) | 2017-10-03 | 2020-12-01 | Seres Therapeutics, Inc. | manipulação do metabolismo da triptamina |
| BR112020008552A2 (pt) | 2017-10-30 | 2020-12-29 | Seres Therapeutics, Inc. | métodos e composições para tratamento de resistência a antibiótico |
| BR112020023933A2 (pt) | 2018-05-24 | 2021-04-27 | Seres Therapeutics, Inc. | composições bacterianas projetadas e usos destas |
-
2014
- 2014-03-17 WO PCT/US2014/030817 patent/WO2014145958A2/en not_active Ceased
- 2014-03-17 JP JP2016502561A patent/JP2016519664A/ja active Pending
- 2014-03-17 HK HK16108497.3A patent/HK1220326A1/zh unknown
- 2014-03-17 US US14/777,252 patent/US10076546B2/en active Active
- 2014-03-17 AU AU2014232370A patent/AU2014232370B2/en active Active
- 2014-03-17 EP EP14763266.5A patent/EP2967077A4/en not_active Withdrawn
-
2018
- 2018-05-25 US US15/990,539 patent/US10881696B2/en active Active
-
2019
- 2019-01-31 AU AU2019200628A patent/AU2019200628B2/en active Active
- 2019-05-08 JP JP2019088423A patent/JP7136743B2/ja active Active
-
2021
- 2021-01-04 US US17/140,385 patent/US11666612B2/en active Active
- 2021-05-25 AU AU2021203396A patent/AU2021203396A1/en not_active Abandoned
-
2022
- 2022-09-01 JP JP2022138978A patent/JP2022188020A/ja active Pending
-
2024
- 2024-08-23 JP JP2024141842A patent/JP2024167277A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11666612B2 (en) | Network-based microbial compositions and methods | |
| JP7409743B2 (ja) | 病原性細菌生育の抑制のための組成物および方法 | |
| JP2016519664A5 (https=) | ||
| CN105979952B (zh) | 协同细菌组合物以及其制造方法和用途 | |
| CA2906921C (en) | Network-based microbial compositions and methods |